Q4 2022 interim report – Webcast presentation – Clinical Development Study finalized and ISO 9001 Certification confirmed

Bergen, Norway 11 may 2023

Today Lifecare publish Q1 2023 interim report. 

The consolidated group financials show a revenue in Q1 of 2.61 MNOK, compared to
1,98 MNOK in Q1 2022, while the Operating result in Q1 2023 ended at -6.38 MNOK,
up from -4,88 MNOK in Q1 2022 due to increase in company's activities after
reaching the clinical stage. 

On the operational side the company can today disclose